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Abstract Robotic surgery, used generally for colorectal can-
cer, has the advantages of a three-dimensional surgical view,
steadiness, and seven degrees of robotic arms. However, there
are disadvantages, such as a decreased sense of touch, extra
time needed to dock the robotic cart, and high cost. Robotic
surgery is performed using various techniques, with or with-
out laparoscopic surgery. Because the results of this approach
are reported to be similar to or less favorable than those of
laparoscopic surgery, the learning curve for robotic colorectal
surgery remains controversial. However, according to short-
and long-term oncologic outcomes, robotic colorectal surgery
is feasible and safe compared with conventional surgery.
Advanced technologies in robotic surgery have resulted in
favorable intraoperative and perioperative clinical outcomes
as well as functional outcomes. As the technical advances in
robotic surgery improve surgical performance as well as out-
comes, it increasingly is being regarded as a treatment option
for colorectal surgery. However, a multicenter, randomized
clinical trial is needed to validate this approach.
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Introduction
As the number of minimally invasive surgeries has in-
creased, robotic surgery has gradually developed in var-
ious surgical fields. The first robot used in the surgical
field was the automated endoscopic system for optimal
positioning (AESOP; Computer Motion, Santa Barbara,
CA), approved for clinical use by the US Food and
Drug Administration in 1994. Later, the Zeus surgical
system was invented but was used only as a surgical
assistant. Today, the da Vinci® robotic system
(Intuitive Surgical Inc., Sunnyvale, CA, USA) is the
most popular surgical system for robotic surgery.
In colorectal surgery, the advanced technologies of
robotic surgery have been allowed more meticulous dis-
section compared with conventional surgeries. Although
laparoscopic surgery has advantages such as fast recov-
ery times and favorable oncologic outcomes, laparoscop-
ic total mesorectal excision (TME) for rectal cancer is a
technically demanding procedure because of the narrow
surgical field in the pelvic cavity. However, the ergo-
nomic design and developed technologies of the robotic
system can overcome these limitations.
The first robotic colorectal surgery was performed in
2001. Robotic colorectal surgery was reported in 2002
by Weber et al. [1] for benign disease and by
Hashizume et al. [2] for malignant disease. D’Annibale
et al. [3] performed 53 colorectal surgeries in 2003, and
Pigazzi et al. [4] reported robotic TMEs for rectal can-
cer in 2006. Because of these developments in robotic
surgery, it now is regarded as one of the treatment op-
tions for colorectal cancer. Therefore, in this article, we
review the characteristics and overall clinical outcomes
of robotic colorectal surgery.
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Characteristics of Robotic Surgery: Advantages
vs. Disadvantages
Robotic surgery for colorectal cancer has several advantages
over conventional surgery in performing precise dissection. It
provides the surgeon with a three-dimensional surgical view,
eliminates instrument tremor, and reduces movement of the
robotic interface. Moreover, the tips of the robotic arms are
ergonomically designed with an EndoWrist, which has seven
degrees of freedom with 180° articulation, which allow me-
ticulous dissection of TME and aid in intraperitoneal suturing.
The improved visual systems of robotic surgery also are useful
in pelvic autonomic nerve preservation [5, 6]. In addition, the
surgeon can perform the operation ergonomically while
seated. Pigazzi et al. [4] reported that this ergonomic design
might result in less fatigue for the surgeon compared with
conventional laparoscopic surgery.
However, robotic surgery has the disadvantage of provid-
ing less tactile sensation and tensile feedback to the surgeon
compared with conventional surgeries, important drawbacks
when manipulating tissue during an operation. In addition, the
docking procedures of robotic carts are time consuming and
require more assistants. Also, the robotic cart may be difficult
to remove quickly if open conversion is needed because of
urgent intraoperative bleeding. Collisions between robotic
arms present another difficulty in using this technology to
perform rectal cancer surgery.
Another important drawback regarding robotic surgery is
its cost, which has limited its use universally. Park et al. [7••]
reported that robotic surgery cost 2.34 times more than lapa-
roscopic surgery in South Korea because robotic surgery is not
covered by the health insurance system in that country.
Whereas the total mean cost of laparoscopic surgery was
$10,101.3±2804.8 (US dollars) and that of robotic surgery
was $12,742.5±3509.9 (US dollars) (P<0.001). Moreover,
Baek and colleagues [8, 9] reported that total hospital charges
after robotic rectal cancer surgery were $14,647, higher than
the $9978 reported after laparoscopic surgery. Patients under-
going robotic surgery paid $11,540 out of pocket, whereas
those in the laparoscopic group paid $3956. Although total
hospital charges and the patient’s bill for robotic surgery were
higher than those for laparoscopic surgery, the cost-
effectiveness of robotic surgery was not demonstrated.
Therefore, a need exists to assess its cost-effectiveness com-
pared with functional and oncologic outcomes.
Surgical Techniques: Hybrid vs. Totally Robotic
Techniques
Robotic colorectal surgery uses several techniques, such as the
hybrid, totally robotic, reverse-hybrid, and natural orifice
specimen extraction (NOSE) techniques. The hybrid
technique comprises both laparoscopic and robotic procedures
[10–12]. Laparoscopy is performed to ligate the inferior mes-
enteric vessels and to mobilize the splenic flexure. Then, pel-
vic dissection for TME is performed by the robotic system.
Because this technique uses laparoscopic tools for splenic
flexure mobilization, there is no need to change robotic carts
when redocking. Placement of the working ports for the hy-
brid technique was shown in Fig. 1.
On the other hand, in totally robotic surgery, all procedures
are performed by the robotic system. However, because splen-
ic flexure colonic mobilization is limited after the robotic carts
are docked, the position of the carts must be changed during
surgery. Today, however, with advancements in port place-
ment, this procedure may be performed as a single-stage or
two-stage dissection [13–15]. Placement of the working ports
for totally robotic surgery was shown in Figs. 2 and 3. Single-
stage totally robotic surgery uses extra robotic ports to avoid
the need to reposition the robotic cart. Some authors assert that
the totally robotic technique allows more precise dissection of
harvested lymph nodes and vessel ligation [13, 14]. However,
others report that full splenic mobilization is difficult using a
totally robotic approach with single docking [12, 16]. In ad-
dition, Baik et al. [17•] reported that compared with the hybrid
technique, totally robotic surgery had a longer operative time,
lower numbers of harvested lymph nodes, and a higher rate of
anastomotic leakage. However, although the hybrid and total-
ly robotic techniques differ with regard to robotic procedures,
both are performed universally with satisfactory feasibility
and safety profiles [14].With each new port placement design,
robotic surgery can be performed by various techniques.
In the reverse-hybrid technique, the robotic interface is
used during pelvic dissection, and then laparoscopy is per-
formed for exploration [16]. Robotic dissection is performed
to ligate the inferior mesenteric vessels and for TME; laparos-
copy then is undertaken to mobilize the splenic flexure, using
the same ports as those of the robotic portion. This approach is
useful in radical lymphovascular and pelvic dissection, and
there is no need for redocking or repositioning.
The NOSE technique differs from the other procedures de-
scribed here with regard to transvaginal or transanal retrieval
of specimens using robotic suturing techniques [18–20]. Choi
et al. [19] reported their early experience with NOSE using
robot-assisted laparoscopic rectal surgery in 2009. This tech-
nique is regarded as useful in rectal cancer surgery because it
avoids traditional abdominal incisions while satisfying both
feasibility and safety requirements. Because the NOSE tech-
nique was developed for easy specimen retrieval, patients
must be selected carefully to eliminate those with bulky tu-
mors. Possible contamination of the site during specimen re-
trieval may be prevented by using an endobag. Based on pre-
vious reports, robotic-assisted colorectal surgery with
transanal or transvaginal specimen removal is considered safe
and acceptable.
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Learning Curve for Robotic Surgery
The learning curve for robotic colorectal surgery consists of
multiple phases. According to Park et al. [21], it comprises
three stages based on multidimensional statistical analyses,
with most studies reporting an initial phase of 25 to 44 cases
[21–23]. After completing the initial stage of the learning
curve, surgeons enter the technical competency phase, after
which they are ready for the challenge of more technically
demanding cases. Based on these observations, recent studies
have demonstrated that the learning curve for robotic colorec-
tal surgery is composed of three phases [21–26].
Compared with the learning curve for laparoscopic colo-
rectal surgery, it is still controversial whether that of robotic
surgery is shorter. Some studies reported that the learning
curve for robotic surgery is shorter because the robotic system
has overcome the technical difficulties associated with lapa-
roscopy [12]. However, a recent study asserted that the learn-
ing curves for both methods are similar [24]. Although the
robotic system has several technical advantages, the authors
suggested that the achievement of TME and basic surgical
skills for rectal cancer surgery might be more important than
the surgical method used. Whereas laparoscopic surgery re-
quires the cooperation of a surgical team, as well as the ability
to manipulate rigid laparoscopic tools in the narrow pelvic
cavity, robotic surgery requires the ability to set the robotic
Fig. 1 Placement of the working ports for the hybrid technique. A 12-mm
camera port; B 8-mm robot port; C 8-mm robot port, used for specimen
delivery; D 8-mm robot port; E 11-mm port for assistant
Fig. 2 Placement of the working
ports for two-stage totally robotic
surgery. A 12-mm camera port;
B, C 8-mm robot port; D 12-mm
port for assistant; E, F 8-mm
robot port. In the lateral phase,
B–D are used for working port.
In the pelvic dissection, B, E, and
F are used for working port for
TME
Fig. 3 Placement of the ports for single-stage totally robotic surgery. A
12-mm camera port, B–F 8-mm robot ports. The distance of B and C
is 7–8 cm from the camera port (A). D is used for specimen delivery.
E is placed 5–6 cm apart from C on the right anterior axillary line.
F is placed above the level of the umbilicus on the left mid-abdomen
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arms without collision as well as adaptation to the robotic
system. Outcomes regarding the learning curve of laparoscop-
ic versus robotic colorectal surgery are still under debate.
Intraoperative and Perioperative Outcomes
The short-term clinical outcomes of robotic colorectal surgery
show it to be feasible and safe. Regarding intraoperative out-
comes, most studies report a longer operative time for robotic
versus laparoscopic surgery [20, 27–29]; however, some au-
thors using the hybrid robotic technique reported that its op-
erative time is similar to that of laparoscopic surgery [24,
30–32]. Differences between these methods might be a result
of the initial learning curve for robotic surgery and the tech-
nical differences between the totally robotic and the hybrid
techniques. Repositioning of robotic carts and redocking dur-
ing totally robotic procedures may be obstacles in reducing
surgical time.
With regard to estimated blood loss (EBL) during robotic
surgery, it is less than or equal to EBL with laparoscopic
surgery. A meta-analysis comparing robotic with laparoscopic
TME found no significant differences in EBL between these
procedures [32]. In most studies of robotic TME, EBL during
robotic surgery was similar to EBL during laparoscopic sur-
gery [28, 32–35].
Length of hospital stay (LOS) for patients undergoing ro-
botic surgery was shorter than or similar to that of laparoscop-
ic surgery patients [31], with a mean LOS of approximately 5
to 7 days. In addition, robotic surgery patients showed faster
recoveries; the number of days to first passing of flatus and
first diet was less than or similar to that in laparoscopic surgery
patients [12, 27–31, 36].
The conversion rate for robotic TME is estimated to be 0 to
7.3 % [36]. Although some studies found no difference in
conversion rates between robotic and laparoscopic surgery
[12, 27, 30, 37], other studies reported a lower rate for robotic
surgery [31, 38]. Conversion from robotic surgery was influ-
enced by high body mass index, intraoperative bleeding, se-
vere adhesions, technical difficulties regarding anatomy, and
bowel dilatation. In addition, the space in which the robotic
arms are manipulated in the abdominal cavity is limited,
which also may affect the conversion rate [35].
With regard to complications, robotic surgery has shown
lower or similar rates compared with laparoscopic surgery. In
most studies, anastomotic leakage was a common postopera-
tive complication, at a rate of 5 to 11 %. Baik et al. [31]
reported that the rate of postoperative complications from ro-
botic surgery was 5.4 %, compared with 19.3 % for laparo-
scopic surgery (P=0.025). Other studies, however, showed
similar postoperative morbidity rates between robotic and lap-
aroscopic surgery [12, 29, 32, 35, 37]. The technical advan-
tages of robotic surgery, including precise dissection and
advanced visual systems, have resulted in favorable perioper-
ative outcomes. The lower or similar postoperative complica-
tion rates for robotic surgery may result in faster recovery and
fewer days of hospital stay.
Functional Outcomes: Urinary and Sexual Function
Urinary and sexual dysfunction showed improvement and fa-
vorable outcomes after robotic rectal cancer surgery.
Urogenital and sexual dysfunction due to injury to the pelvic
autonomic nerves during dissection is assessed by the
International Prostate Symptom Score (IPSS) and the
International Index of Erectile Function (IIEF) questionnaires.
D’Annibale et al. [38] reported that in both robotic and lapa-
roscopic patient groups, IPSS significantly increased 1 month
after surgery but normalized 1 year after surgery. Erectile
function was reduced 1 month after surgery but was complete-
ly restored 1 year after surgery in the robotic group and was
partially restored in the laparoscopic group. In comparing
voiding and sexual function after TME in laparoscopic versus
robotic surgical patients, Kim et al. [5] found similar results:
IPSS increased 1 month after surgery but normalized at
3 months in the robotic group and at 6 months in the laparo-
scopic group. IIEF scores in the laparoscopic group normal-
ized within 12 months, versus 6 months in the robotic group.
In addition, Park et al. [39] reported earlier restoration of erec-
tile function and significantly higher IIEF scores at 6 months
in the robotic group versus the laparoscopy patients. Recent
studies also demonstrate earlier and better recovery of voiding
and sexual function in patients undergoing robotic rectal can-
cer surgery [39–42]. Although a large randomized, prospec-
tive study is needed, the technical advantages of robotic sur-
gery in allowing more precise and meticulous dissection may
be the reason for these favorable outcomes in urogenital and
sexual function after surgery.
Oncologic Outcomes: Short and Long Term
To the best of our knowledge, the short-term and long-term
oncologic outcomes of robotic surgery for rectal cancer are
similar to those with laparoscopic surgery, even though robot-
ic surgery uses more advanced technical methods.
Regarding short-term oncologic outcomes, Baek et al. re-
ported that the 3-year overall survival (OS) rate after robotic
colorectal surgery was 96.2 %, with a 3-year disease-free sur-
vival (DFS) rate of 73.7 % during a mean 20.2-month follow-
up period. In addition, in a multicenter study of robotic TME,
Pigazzi et al. [43] reported a 3-year OS of 97 % and a 3-year
DFS of 77.6 % at a mean follow-up of 17.4 months; there was
no local recurrence during the study period. In their analysis of
pathologic outcomes of robotic surgery, Bianchi et al. [30]
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demonstrated that the number of harvested lymph nodes and
the circumferential resection margin (CRM) did not differ
from those achieved with laparoscopic surgery. Baik et al.
[31] reported similar pathologic outcomes in patients under-
going robotic and laparoscopic surgery, although the speci-
mens resected in the robotic groupweremoremacroscopically
complete, which along with proper harvesting of lymph
nodes, is related to oncologic outcome [44].
Because better-quality or more complete resection speci-
mens reflect the effectiveness of TME for rectal cancer, they
represent important advantages of robotic surgery. For this
reason, robotic surgery would be expected to result in better
long-term oncologic outcomes. However, the long-term onco-
logic outcomes of robotic surgery for rectal cancer are similar
to those of laparoscopic surgery. In analyzing the long-term
oncologic outcomes of robotic rectal cancer surgery, Park
et al. [7••] found no significant differences in 5-year OS,
DFS, or local recurrence rates between patients treated with
robotic and those treated with laparoscopic surgery for rectal
cancer during a median follow-up period of 58months. The 5-
year OS and DFS rates were 92.8 and 81.9 % in the robotic
surgery group, respectively. Local recurrence was similar in
both the robotic and laparoscopic groups (2.3 and 1.2 %, re-
spectively; P=0.649). In a case-matched study, Cho et al. [27]
reported 5-year OS, DFS, and local recurrence rates of 93.1,
79.6, and 3.9 %, respectively, in patients undergoing TME
using the totally robotic technique, which did not differ sig-
nificantly from the rates observed in patients undergoing lap-
aroscopic TME. Based on 200 consecutive cases of robotic
surgery for rectal cancer, Hara et al. [45] reported a recurrence
rate of 13.5 %, which included rates of 3.5 % for local recur-
rence, 9.5 % for distant metastasis, and 1.0 % for both local
and distant metastasis. Because long-term oncologic out-
comes of robotic colorectal surgery are unknown and only
single-center experience exists, these outcomes must be vali-
dated by randomized, multicenter clinical trials.
Now under way is a clinical trial known as Robotic versus
Laparoscopic Resection for Rectal Cancer (ROLARR;
NCT01736072) [46]. This study is an international, prospec-
tive, randomized, controlled, unblinded, superiority trial com-
paring robotic and laparoscopic surgery for rectal cancer. The
results of this trial are expected to suggest level I evidence for
robotic rectal cancer surgery.
Robotic Surgery for Colon Cancer
Robotic surgery for colon cancer, first reported in 2002, gen-
erally is performed for both right-sided and left-sided colon
cancers. Robotic right colon resection with intracorporeal
anastomosis was reported by Trastulli and coworkers [47,
48], with feasible and safe results. In colon cancer surgery,
complete mesocolic excision (CME) is a concept similar to
that of TME in rectal cancer. Because the colonicmesentery or
mesocolon is responsible for the vascular and lymphatic drain-
age of the colon, previous studies considered CME to be
oncologically beneficial [49]. As the robotic system has tech-
nical advantages in rectal cancer surgery, CME with central
vascular ligation also can be performed by robotic surgery [48,
50, 51]. Cho et al. [52] compared open andminimally invasive
surgeries for modified CME in patients with right-sided colon
cancer. Mathew et al. [48] reported a robotic right
hemicolectomy with D3 lymphadenectomy and CME.
In addition, Lim et al. [53] reported robotic anterior resec-
tions for sigmoid colon cancer. Although the mean total oper-
ative time for robotic surgery was longer than that for laparo-
scopic surgery (252.5±94.9 vs. 217.6±70.7 min, respective-
ly; P=0.016), the mean time to soft diet and length of hospital
stay were shorter for patients in the robotic surgery group
versus those in the laparoscopic group. The perioperative
and oncologic outcomes for robotic anterior resection were
feasible.
Although it is more difficult to move in multiquadrant
spaces in the abdomen with robotic than with laparoscopic
surgery, robotic colon cancer surgery is performed universally
nowadays.
Advanced Techniques in Robotic Surgery
Recently, robotic surgery has shown its feasibility for use in
challenging cases, with studies reporting results of robotic
extralevator abdominoperineal resection (ELAPR). Although
performing dissection in a narrow pelvic cavity is difficult, the
technical features of robotic surgery are useful in dissecting
low rectal cancer or anal cancer for ELAPR [54–56]. In addi-
tion, Shin et al. [57] reported robotic pelvic exenteration for
locally advanced rectal cancer invading the prostate and sem-
inal vesicles, suggesting a potential role for robotic surgery in
advanced rectal cancer. In selected cases, robotic procedures
may be feasible for en bloc resection within adjacent involved
organs.
Parallel to the development of robotic technology, the in-
traoperative near-infrared fluorescence (INIF) imaging system
(Firefly™, Intuitive Surgical Inc.) has been used to identify
vascular anatomy in real time during surgery. The INIF imag-
ing system uses laser technology while activating indocyanine
green dye intravenously. As surgeons switch from normal
vision to INIF imaging on the surgical console, they can better
identify vessel anatomy and lymph node dissection. Bae et al.
[58, 59] reported that this technique made it easier to identify
the left colic vessels as well as making lymph node dissection
for robotic TME more precise.
Recently, robotic surgery using a single port site was re-
ported. According to similar experience with the da Vinci
Single-Site Port (Intuitive Surgical Inc.), reduced-port robotic
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surgery for left-sided colorectal cancer was reported using a
robotic single-access platform [60]. Based on these efforts,
robotic surgery has the potential to overcome the limitations
of conventional surgeries.
Conclusions
Based on the short- and long-term outcomes of robotic surgery
for colorectal cancer, this technique has a good feasibility and
safety profile. The advanced technologies of robotic surgery
have resulted in favorable intraoperative and perioperative clin-
ical outcomes as well as functional outcomes. Because the
technical advantages of robotic surgery have improved surgical
performance in colorectal surgery, robotic surgery is now
regarded as a treatment option for patients with this disease.
To validate robotic colorectal surgery further, however, the re-
sults of a multicenter, randomized clinical trial are required.
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